Summary
This is a combined synopsis/solicitation (RFP, solicitation number 75N95026R0007) issued by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to examine the role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders and other health outcomes in people living with HIV. The work will use Veterans Affairs electronic health record data and apply propensity-score matching and multivariable linear regression to estimate changes in outcomes. Responses must be submitted electronically to the contracting officer (Robin Knightly, Robin.Knightly@nih.gov) by the deadline; NAICS 541690 with no set-aside.